Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV-13 vaccine use in childhood acute lymphoblastic leukemia
ISRCTN12861513Phase 4Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Sep 2010
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 4, open-label, single-arm trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Serum IgG anti-capsular polysaccharide antibody concentrations at 12 months. Started Sep 2010; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on ISRCTN12861513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12861513.